{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T14:38:03Z","timestamp":1725892683709},"reference-count":22,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/jpids\/piy045","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T07:15:58Z","timestamp":1525072558000},"source":"Crossref","is-referenced-by-count":1,"title":["Cutaneous Leishmaniasis in an American Adolescent Returning From Israel"],"prefix":"10.1093","author":[{"given":"Kimia G","family":"Ganjaei","sequence":"first","affiliation":[{"name":"Rutgers-Robert Wood Johnson Medical School, Piscataway, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira","family":"Lawton","sequence":"additional","affiliation":[{"name":"Rutgers-Robert Wood Johnson University Hospital, New Brunswick, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunanda","family":"Gaur","sequence":"additional","affiliation":[{"name":"Robert Wood Johnson AIDS Program, Pediatric Infectious Diseases, Bristol-Myers Squibb Children\u2019s Hospital at Robert Wood Johnson University Hospital, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,6,6]]},"reference":[{"key":"key\n\t\t\t\t20180605212720_CIT0001","first-page":"557","volume-title":"Global leishmaniasis update, 2006\u20132015: a turning point in leishmaniasis surveillance","author":"Postigo","year":"2017"},{"key":"key\n\t\t\t\t20180605212720_CIT0002","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.15-0860","article-title":"Successful treatment of cutaneous leishmaniasis with topical paramomycin in a child after treatment failure with systemic fluconazole","volume":"95","author":"Chacko","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180605212720_CIT0003","first-page":"73","volume-title":"Cutaneous leishmaniasis in North Dakota","author":"Douvojannis","year":"2014"},{"key":"key\n\t\t\t\t20180605212720_CIT0004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/DAD.0000000000000119","article-title":"Isolated cutaneous leishmaniasis by Leishmania donovani in a soldier returning from Afghanistan","volume":"37","author":"Nagarajan","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"key\n\t\t\t\t20180605212720_CIT0005","first-page":"2","article-title":"Incident diagnoses of leishmaniasis, active and reserve components, United States forces, 2001\u20132016","volume":"2","author":"Stahlman","year":"2017","journal-title":"MSMR"},{"key":"key\n\t\t\t\t20180605212720_CIT0006","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.clindermatol.2014.02.013","article-title":"Rarely seen infections","volume":"32","author":"Amer","year":"2014","journal-title":"Clin Dermatol"},{"key":"key\n\t\t\t\t20180605212720_CIT0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous leishmaniasis: recent developments in diagnosis and management","volume":"16","author":"de Vries","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"key\n\t\t\t\t20180605212720_CIT0008","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180605212720_CIT0009","volume-title":"Leishmaniasis: epidemiology and risk factors","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"key\n\t\t\t\t20180605212720_CIT0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1017\/S0031182017000385","article-title":"Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review","volume":"144","author":"Nassif","year":"2017","journal-title":"Parasitology"},{"key":"key\n\t\t\t\t20180605212720_CIT0011","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study","volume":"3","author":"Ben Salah","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180605212720_CIT0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-4362.1997.00022.x","article-title":"A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey","volume":"36","author":"Ozgoztasi","year":"1997","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t20180605212720_CIT0013","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180605212720_CIT0014","doi-asserted-by":"crossref","first-page":"e2749","DOI":"10.1371\/journal.pntd.0002749","article-title":"Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream","volume":"8","author":"Salah","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180605212720_CIT0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"Salah","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180605212720_CIT0016","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archderm.1996.03890310070009","article-title":"Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study","volume":"132","author":"Momeni","year":"1996","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t20180605212720_CIT0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/09546630305552","article-title":"Treatment of cutaneous leishmaniasis with ketoconazole cream","volume":"14","author":"Momeni","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"key\n\t\t\t\t20180605212720_CIT0018","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2010.04.014","article-title":"Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous Leishmania major infection: a randomized clinical trial","volume":"64","author":"Emad","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20180605212720_CIT0019","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180605212720_CIT0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20180605212720_CIT0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/648726","article-title":"Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan","volume":"50","author":"van Thiel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180605212720_CIT0022","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial","volume":"4","author":"Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piy045\/25013365\/piy045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T06:30:38Z","timestamp":1571293838000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article\/doi\/10.1093\/jpids\/piy045\/5033485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,6]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1093\/jpids\/piy045","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,6]]}}}